Clinical Trials
23
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Trial of the Efficacy and Safety of Use of Drug Product Reamberin® for Pathogenetic Therapy of Viral Enteric Infection in Children Aged 1-6 Years Old
- Conditions
- Viral Enteric Infection
- Interventions
- Drug: Reamberin® solution for infusion, 1.5 %
- First Posted Date
- 2025-07-15
- Last Posted Date
- 2025-07-15
- Target Recruit Count
- 300
- Registration Number
- NCT07066540
- Locations
- 🇷🇺
South Ural State Medical University, Chelyabinsk, Russian Federation
🇷🇺Khimki Clinical Hospital, Khimki, Russian Federation
🇷🇺Kuban State Medical University, Krasnodar, Russian Federation
REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis
- Conditions
- Diabetic Ketoacidosis
- Interventions
- Drug: ReamberinDrug: Placebo
- First Posted Date
- 2025-05-02
- Last Posted Date
- 2025-06-24
- Target Recruit Count
- 312
- Registration Number
- NCT06955416
- Locations
- 🇷🇺
Kuzbass Clinical Hospital of Emergency Medical Care named after M.A. Podgorbunsky, Kemerovo, Russian Federation
🇷🇺State Budgetary Institution of Healthcare of the Arkhangelsk Region "First City Clinical Hospital named after E.E. Volosevich", Arkhangelsk, Russian Federation
🇷🇺Regional budgetary healthcare institution "Ivanovo regional clinical hospital", Ivanovo, Russian Federation
Evaluation of the Efficacy of Permanent Course Combined Therapy With CYTOFLAVIN® Intravenous Solution and CYTOFLAVIN Tablets, at 2-3 Stages of Rehabilitation of Patients With Post Intensive Care Syndrome
- Conditions
- Ischemic Stroke
- First Posted Date
- 2024-12-16
- Last Posted Date
- 2025-04-06
- Target Recruit Count
- 90
- Registration Number
- NCT06735898
- Locations
- 🇷🇺
Brain Institute Clinic, Ekaterinburg, Sverdlovsk region, Russian Federation
Observational Study of Efficiency of Cytoflavin, in Patients With Ischemic Stroke Not Receiving Reperfusion Therapy
- First Posted Date
- 2024-07-23
- Last Posted Date
- 2025-04-18
- Target Recruit Count
- 562
- Registration Number
- NCT06514976
- Locations
- 🇷🇺
"Ivanovo Regional Clinical Hospital", Ivanovo, Russian Federation
🇷🇺Kazan State Medical University, Kazan, Russian Federation
🇷🇺State Autonomous Institution of Health Interregional clinical diagnostic center, Kazan, Russian Federation
Study of Safety and Efficacy of the Drug Cycloferone in Patients with Acute Respiratory Viral Infection
- Conditions
- Acute Respiratory Viral Infection
- Interventions
- Drug: Cycloferone
- First Posted Date
- 2024-02-29
- Last Posted Date
- 2024-12-16
- Target Recruit Count
- 742
- Registration Number
- NCT06286254
- Locations
- 🇷🇺
Clinic Zvezdnaya, Saint Petersburg, Russian Federation
🇷🇺Medical center Astarta, Saint Petersburg, Russian Federation
🇷🇺Medical Center Energiya Zdoroviy, Saint Petersburg, Russian Federation
- Prev
- 1
- 2
- 3
- 4
- 5
- Next